Steady state BE study dosing [Design Issues]

posted by dshah  – India/United Kingdom, 2024-01-22 11:09 (182 d 15:30 ago) – Posting: # 23837
Views: 1,785

Hi NK!

❝ Kindly clarify, whether 2nd and 3rd dose on day 5 need to be administered or not? and sampling should be continued for 24 hours?

So you are asking for protocol preparation consideration. The study is in healthy volunteers- so I believe that AUC0-t/AUC0-inf>=0.8 also needs to be followed, so consider sampling accordingly.


Complete thread:

UA Flag
 Admin contact
23,113 posts in 4,858 threads, 1,644 registered users;
39 visitors (0 registered, 39 guests [including 9 identified bots]).
Forum time: 03:39 CEST (Europe/Vienna)

You can’t really say “similar” if it’s the same again you want.
“Similar” means something different.    Anthony Burgess

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz